Merck Sharpe & Dohme sues Sandoz to block Januvia generic

Healthcare 2021-02-15 9:43 pmBy Spencer Fowler Steen | Melbourne

Please login to bookmark

US pharmaceutical giant Merck Sharp & Dohme has taken Sandoz to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Janumet and Januvia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au